1-4 of 4
Hsiao-Ting Hsu
Close
Sort by
Journal Articles

Interleukin 2 Receptor-α (CD25) Expression Is Associated with Shortened Overall Survival and Resistance to Induction Therapy with Plerixafor and Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

John N. Allan, MD, Gail J. Roboz, MD, Eric J. Feldman, MD, Joseph M. Scandura, MD PhD, Ellen K. Ritchie, MD, Linda Lam, Wen Xie, Hsiao-Ting Hsu, MS, Duane C Hassane, PhD, Monica L. Guzman, PhD
Journal: Blood
Blood (2014) 124 (21): 1041.
https://doi.org/10.1182/blood.V124.21.1041.1041
Published: 2014
Journal Articles

Combining Decitabine With Plerixafor Yields a High Response Rate In Newly Diagnosed Older Patients With AML

Gail J. Roboz, MD, Joseph M. Scandura, MD, PhD, Ellen Ritchie, MD, Yulia Dault, RN, Linda Lam, Wen Xie, Hsiao-Ting Hsu, Danielle Marshall, Paul J Christos, Cindy Ippoliti, Eric J. Feldman, MD, Monica L. Guzman, PhD
Journal: Blood
Blood (2013) 122 (21): 621.
https://doi.org/10.1182/blood.V122.21.621.621
Published: 2013
Journal Articles

A-Type Proanthocyanidins Prevent Engraftment Of Primary Acute Myelogenous Leukemia Cells In Mice and Exhibit Potentially Novel Anti-Leukemia Mechanisms

Laura M Bystrom, PhD, Hongliang Zong, MD, PhD, Hsiao-Ting Hsu, MS, Neng Yang, MD, PhD, Noa Greenberg, MD, Qinghao Wang, MD, PhD, Catherine Neto, PhD, Maolin Guo, PhD, Stefano Rivella, PhD, Monica L. Guzman, PhD
Journal: Blood
Blood (2013) 122 (21): 3962.
https://doi.org/10.1182/blood.V122.21.3962.3962
Published: 2013
Journal Articles

A-Type Proanthocyanidins From Cranberries Target Acute Myelogenous Leukemia Stem Cells.

Laura Bystrom, Ph.D., Hsiao-Ting Hsu, MS, Catherine Neto, Ph.D., Gail J. Roboz, MD, Duane C Hassane, PhD, Stefano Rivella, Ph.D, Monica L. Guzman, PhD
Journal: Blood
Blood (2012) 120 (21): 2986.
https://doi.org/10.1182/blood.V120.21.2986.2986
Published: 2012